 | Luven (LVN)ICO The LUVEN screening test method detects cancer at its early stages with the accuracy of up to 96%. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenTechnical details
Ethereum ERC20 standard token.
What is Luven
- already completed 90% of the project.
Token holders have two opportunities:
- receiving a part of the company income
- exchanging their tokens for testing services with a 30% discount, using or selling them to wholesale customers
DetailsPre-sales: Dec 11, 2017 - Dec 28, 2017Public sales: Jan 14, 2018 - Feb 27, 2018 Raised: 26,350 USD BountyBounty: 3%Translation: 10% Social media: 70% Bitcoin talk signature campaign: 20 % | Token infoTicker: LVNType: Utility-token Token standard: ERC-20 Token price in USD: 1 Token = 1.000000 USD Accepted currencies: ETH, BTC Bonus program: At the preICO stage - 3 000 000 tokens (1st day bonus – 30%, 1st week bonus – 25%, 2nd week bonus – 20%, 3d week bonus – 15%) At the ICO stage - 27 000 000 (1st week – 10%, 1 to 1 onwards) Referral program 5% purchased by referral Funds allocation: Clinical trials 40% Marketing 25% Software 15% Legal part 10% Team remuneration 7% Bounty campaign 3% |
Luven Roadmap
Development ofthe cancer diagnostic method started, based on the study of buccal cells (cells from the inside ofthe cheek)
A cytomorphobiologial diagnostic method appeared which formed the basis ofthe diagnostic complex
Team expansion. A commercial enterprise promoting the LUVEN trademark was established. The software automating a part ofthe diagnostic procedure was created.
The diagnostic method was patented, completion of the clinicaltrials, creation ofthe software diagnostic complex presented at two international medical exhibitions The 5th International Medical Forum and Health Care 2014. Opening first franchise outlets.
In five months after launching a franchise, the contracts were signed with more than twenty outlets, half of which have already run tests on more than two thousand patients. Suspension of activities for a time allowing technology enhancement.
Software enhancement, additional clinicaltrials. Optimizing a big number ofthe system algorithms
Preparing and starting a preICO aimed at fundraising for the software enhancement, legal costs and operational expenses ofthe project
Starting an ICO
Further software enhancement, signing contracts with clinics worldwide for conducting clinicaltrials, opening a research center in Austria. Initiating certification ofthe method in the European Union and Eurasian Union
Opening 20 new labs in the European Union and Eurasian Union, incorporating a blockchain and developing a domestic exchange for token sale, working on the optical recognition of incoming images ofthe cell, creating a database of patients and their test results for monitoring tendencies and informing patients on the necessity of being diagnosed
Starting clinicaltrials and certification in the USA and Asia
Developing home gadgets (a home lab) for running tests on the entire family at any time, launching the product.
Project team
Social media
